[Bioequivalence and excipients: the case of tirofiban. A warning from the Italian Society of Interventional Cardiology (SICI-GISE)].

Adamo M, Bonmassari R, Bernardi G, Colombo P, Esposito G, Ferlini M, La Manna AG, Limbruno U, Marchese A, Mauro C, Menozzi A, Nicosia A, Rigattieri S, Tarantini G, Tarantino F, Valgimigli M, Varbella F, Musumeci G

Open source

DOI
10.1714/2657.27247
Published
2017 Feb
Container
Giornale italiano di cardiologia (2006)
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1714/2657.27247,
  title = {[Bioequivalence and excipients: the case of tirofiban. A warning from the Italian Society of Interventional Cardiology (SICI-GISE)].},
  author = {Adamo M and Bonmassari R and Bernardi G and Colombo P and Esposito G and Ferlini M and La Manna AG and Limbruno U and Marchese A and Mauro C and Menozzi A and Nicosia A and Rigattieri S and Tarantini G and Tarantino F and Valgimigli M and Varbella F and Musumeci G},
  year = {2017},
  journal = {Giornale italiano di cardiologia (2006)},
  doi = {10.1714/2657.27247},
  url = {https://doi.org/10.1714/2657.27247}
}

RIS

TY  - JOUR
TI  - [Bioequivalence and excipients: the case of tirofiban. A warning from the Italian Society of Interventional Cardiology (SICI-GISE)].
AU  - Adamo M
AU  - Bonmassari R
AU  - Bernardi G
AU  - Colombo P
AU  - Esposito G
AU  - Ferlini M
AU  - La Manna AG
AU  - Limbruno U
AU  - Marchese A
AU  - Mauro C
AU  - Menozzi A
AU  - Nicosia A
AU  - Rigattieri S
AU  - Tarantini G
AU  - Tarantino F
AU  - Valgimigli M
AU  - Varbella F
AU  - Musumeci G
PY  - 2017
JO  - Giornale italiano di cardiologia (2006)
DO  - 10.1714/2657.27247
UR  - https://doi.org/10.1714/2657.27247
ER  - 

APA

M, A., R, B., G, B., P, C., G, E., M, F., AG, L. M., U, L., A, M., C, M., A, M., A, N., S, R., G, T., F, T., M, V., F, V., & G, M. (2017). [Bioequivalence and excipients: the case of tirofiban. A warning from the Italian Society of Interventional Cardiology (SICI-GISE)].. Giornale italiano di cardiologia (2006). https://doi.org/10.1714/2657.27247

Source records